pf-00299804 and Carcinogenesis

pf-00299804 has been researched along with Carcinogenesis* in 1 studies

Other Studies

1 other study(ies) available for pf-00299804 and Carcinogenesis

Article	Year
Targeting the ERβ/HER Oncogenic Network in International journal of molecular sciences, 2021, Dec-22, Volume: 23, Issue:1 High ERβ/HER oncogenic signaling defines lung tumors with an aggressive biology. We previously showed that combining the anti-estrogen fulvestrant with the pan-HER inhibitor dacomitinib reduced ER/HER crosstalk and produced synergistic anti-tumor effects in immunocompromised lung cancer models, including Topics: Animals; Carcinogenesis; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Estrogen Receptor beta; Female; Humans; Immunotherapy; Lung Neoplasms; Lymphocytes, Tumor-Infiltrating; Macrophages; Mice; Oncogenes; Programmed Cell Death 1 Receptor; Proto-Oncogene Proteins p21(ras); Quinazolinones; Receptor, ErbB-2; Tumor Microenvironment	2021

Article

Year

Targeting the ERβ/HER Oncogenic Network in

International journal of molecular sciences, 2021, Dec-22, Volume: 23, Issue:1

High ERβ/HER oncogenic signaling defines lung tumors with an aggressive biology. We previously showed that combining the anti-estrogen fulvestrant with the pan-HER inhibitor dacomitinib reduced ER/HER crosstalk and produced synergistic anti-tumor effects in immunocompromised lung cancer models, including

Topics: Animals; Carcinogenesis; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Estrogen Receptor beta; Female; Humans; Immunotherapy; Lung Neoplasms; Lymphocytes, Tumor-Infiltrating; Macrophages; Mice; Oncogenes; Programmed Cell Death 1 Receptor; Proto-Oncogene Proteins p21(ras); Quinazolinones; Receptor, ErbB-2; Tumor Microenvironment

2021